221 related articles for article (PubMed ID: 4391790)
41. [On the pharmacology of 2-amino-6-methylheptane-(+)-camphor-10-sulfonate].
Oelkers HA
Arzneimittelforschung; 1967 Jan; 17(1):25-8. PubMed ID: 5632522
[No Abstract] [Full Text] [Related]
42. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
Buyniski JP; Losada M; Bierwagen ME; Gardier RW
J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
[No Abstract] [Full Text] [Related]
43. [Pharmacology of dimethylaminoethyl ester of diphenylethoxyacetic acid hydrochloride--estocin].
Kingisepp GIa; Kurvits KhKh; Nurmand LB
Farmakol Toksikol; 1969; 32(6):710-2. PubMed ID: 5381602
[No Abstract] [Full Text] [Related]
44. [Some indices of effect of suprastin on cerebral circulation].
Trafimenko SP
Farmakol Toksikol; 1969; 32(5):542-5. PubMed ID: 4391461
[No Abstract] [Full Text] [Related]
45. [Comparative studies on the effect of coronary dilators on the coronary blood circulation in man].
Hilger HH; Behrenbeck DW; Hellwig H; Wagner J
Arzneimittelforschung; 1970 Mar; 20():441-2. PubMed ID: 5468726
[No Abstract] [Full Text] [Related]
46. [Pharmacology of xylite].
Kryshen' PF; Rafes IuI; Krasovskaia AG; Genbacheva GB; Ardelian VN
Farmakol Toksikol; 1971; 34(3):333-5. PubMed ID: 5568697
[No Abstract] [Full Text] [Related]
47. Cardiovascular actions of sodium nitroprusside in dogs.
Ross G; Cole PV
Anaesthesia; 1973 Jul; 28(4):400-6. PubMed ID: 4577692
[No Abstract] [Full Text] [Related]
48. [Action of isoctamyl on the cardiovascular system].
Avakian OM; Noravian OS
Zh Eksp Klin Med; 1974; 14(2):9-14. PubMed ID: 4408464
[No Abstract] [Full Text] [Related]
49. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties.
Chiba S; Saji Y; Hibino H; Takeo Y; Yui T
Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816
[No Abstract] [Full Text] [Related]
50. [N6-(naphthyl-(1))-methyladenosine, an adenosine derivative with prolonged coronary effect].
Jahn W
Arzneimittelforschung; 1969 May; 19(5):701-4. PubMed ID: 5819777
[No Abstract] [Full Text] [Related]
51. [Characteristic of the effect of catron on blood influx in the ischemic myocardium].
Sapozhkov AV
Farmakol Toksikol; 1970; 33(5):563-7. PubMed ID: 4395398
[No Abstract] [Full Text] [Related]
52. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
Sapozhikov AV
Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
[No Abstract] [Full Text] [Related]
53. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
Schaper WK; Xhoneux R; Jageneau AH; Janssen PA
J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
[No Abstract] [Full Text] [Related]
54. Basic considerations on the use of pressor drugs.
Saito T
Med J Osaka Univ; 1969 Mar; 19(4):309-49. PubMed ID: 4900420
[No Abstract] [Full Text] [Related]
55. [On the pharmacology of erycordin].
Liubetskaia ZhA; Bezruk PI; Angarskaia MA
Farmakol Toksikol; 1969; 32(2):211-4. PubMed ID: 5772148
[No Abstract] [Full Text] [Related]
56. Proceedings: Pharmacological effects of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (BL 191).
Sakurai M; Kitatani T; Nagato K; Sakaguchi T
Jpn J Pharmacol; 1974; 24(0):s:68. PubMed ID: 4546078
[No Abstract] [Full Text] [Related]
57. [Clinical pharmacology of sodium nitroprusside].
Campan L
Neurochirurgie; 1978; 24(3):144-9. PubMed ID: 39269
[No Abstract] [Full Text] [Related]
58. [Pharmacological studies on the effect of synthetic alpha-methyl-pyrryl-ketone on the central nervous system and blood circulation].
Sándor P; Kovách AG; Horváth KB; Szentpétery GB; Clauder O
Arzneimittelforschung; 1970 Jan; 20(1):29-32. PubMed ID: 5467445
[No Abstract] [Full Text] [Related]
59. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
Bassenge E; Doutheil U
Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
[No Abstract] [Full Text] [Related]
60. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
Osborne MW; Wenger JJ; Willems W
J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
